Profiles · Asia’s Most Promising Leaders
Kazuma Kishida
Dioseve · Reproductive Health & Fertility Biotech
Kazuma Kishida co-founded Dioseve in 2021, developing assisted reproductive technology using oocytes derived from iPS cells. A Waseda University graduate with an M&A advisory background at Houlihan Lokey, Kishida has secured JPY 1.45 billion in funding for the Tokyo-based biotech.
Know a brand or leader like this? Nominate them for Power Leaders, Asian Power Brands and Leaders 2026. Entries close 16 October 2026.
Editorial profile compiled from public sources. Facts are confirmed with the subject before the profile is expanded, and the subject may request corrections at editorial@thecoverstory.world.